相关实验视频
Updated: Sep 10, 2025
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.9K
EXPRESS: 周围叶绿素和保持比率受损的精神测量 (PRISm)
Yuhan Wang1, Hailing Liu1, Jingyi Zhang1
1Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
概括
在没有气流阻塞的成年人中,通过高的乙氨基酸计数表明的外周乙氨基酸与保持比率受损的螺旋测量 (PRISm) 有关. 这一发现表明慢性阻塞性肺病发展的潜在早期指标.
科学领域:
- 肺部医学
- 呼吸系统健康
- 临床诊断
背景情况:
- 保持比率受损螺旋计 (PRISm) 是慢性阻塞性肺病 (COPD) 的潜在前体.
- 在PRISm中,外围乙蛋白的作用仍未得到充分研究.
- 了解PRIS的早期特征对于及时干预至关重要.
研究的目的:
- 调查外围乙细胞数量与PRISm之间的关联.
- 为了确定与PRISm和外围好色素相关的人口和临床因素.
- 为了确定外围阴是否是PRISm的独立风险因素.
主要方法:
- 一项涉及7301名20-79岁社区成年人的横截面研究,
- 参与者被分为正常的螺旋测量和PRISm组.
- 用多变量逻辑回归来分析关联.
主要成果:
- 在参与者中,9. 43% 患有PRISm.
- 在特定的小组中,PRISm与外围性黄色素 (≥300细胞/μL) 的更高患病率有关 (例如,年龄在40-79岁之间,非西班牙裔白人,从未吸烟者,没有喘史).
- 周围乙细胞计数≥300细胞/μL与PRISm显著相关 (调整后OR为1. 39;95%CI为1.12,1. 72).
结论:
- 在没有空气流阻塞的个体中,外围阴与PRIS有关.
- 周围乙酸细胞数量升高可以作为PRISm的生物标志物.
- 需要进一步研究PRISm中的外围乙细胞特征.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:25Pulmonary Function Tests
433
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
433